Nadim Hamzaoui

Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas

Olivia Barreau, Guillaume Assié, H. Wilmot-Roussel et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 121 citations · Full text

Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma

Guillaume Assié, Anne Jouinot, Rossella Libé et al. · JAMA Oncology · 2019 · 79 citations · Full text

DNA methylation is an independent prognostic marker of survival in adrenocortical cancer

Anne Jouinot, Guillaume Assié, Rossella Libé et al. · The Journal of Clinical Endocrinology & Metabolism · 2016 · 66 citations · Full text

Serum Interleukin-6, Soluble Interleukin-6 Receptor and Crohn’s Disease Activity

Stéphane Nancey, Nadim Hamzaoui, Driffa Moussata et al. · Digestive Diseases and Sciences · 2007 · 58 citations

Inflammation, Chronic Inflammatory Diseases, Serum Interleukin-6 +4

Cyclooxygenase-2 Inhibitors Down-regulate Osteopontin and Nr4a2—New Therapeutic Targets for Colorectal Cancers

Rachid Zagani, Nadim Hamzaoui, Wulfran Cacheux et al. · Gastroenterology · 2009 · 52 citations · Full text

Nr4a2—new Therapeutic Targets, Oncology, Colorectal Cancers +9